Humana Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Humana Inc. (NYSE:HUM) will release its third-quarter earnings report before the opening bell on Friday, Nov. 6.

Analysts expect the Louisville, Kentucky-based company to report a quarterly loss of $1.00 per share, versus a profit of $3.24 per share in the year-ago period. The consensus estimate for HUM’s quarterly revenue is $40.89 billion. It reported $32.65 billion last year, according to Benzinga Pro.

On Oct. 29, Humana announced that its Board of Directors declared a cash dividend to stockholders of 88.5 cents per share.

Humana shares fell 1.4% to close at $411.79 on Thursday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

• Mizuho analyst Ann Hynes maintained the stock with an Outperform rating and raised the price target from $468 to $495 on Oct. 13, 2026. This analyst has an accuracy rate of 77%.
• UBS analyst A.J. Rice maintained the stock with a Neutral rating and boosted the price target from $405 to $495 on Oct. 12, 2026. This analyst has an accuracy rate of 74%.
• Truist Securities analyst David Macdonald maintained a Hold rating and increased the price target from $415 to $475 on Oct. 12, 2026. This analyst has an accuracy rate of 73%.
• Oppenheimer analyst Michael Wiederhorn maintained an Outperform rating and boosted the price target from $475 to $525 on Oct. 12, 2026. This analyst has an accuracy rate of 65%.
• Raymond James analyst John Ransom upgraded the stock from Market Perform to Outperform with a price target of $520 on Oct. 12, 2026. This analyst has an accuracy rate of 76%.

Considering buying HUM stock? Here’s what analysts think:

Photo via Shutterstock